Additional Proxy Soliciting Materials (definitive) (defa14a)
29 Aprile 2022 - 2:48PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE
14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of
the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant x
Filed by a Party other than the Registrant ¨
Check the appropriate box:
| ¨ |
Preliminary Proxy Statement |
| ¨ |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ¨ |
Definitive Proxy Statement |
| x |
Definitive Additional Materials |
| ¨ |
Soliciting Material under §240.14a-12 |
CHECKPOINT
THERAPEUTICS, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing
Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| ¨ |
Fee paid previously with preliminary materials |
| ¨ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |
| Your Vote Counts!
CHECKPOINT THERAPEUTICS, INC.
ATTN: GARRETT GRAY
95 SAWYER ROAD, SUITE 110
WALTHAM, MA 02453
CHECKPOINT THERAPEUTICS, INC.
2022 Annual Meeting
Vote by June 14, 2022
11:59 p.m. ET
You invested in CHECKPOINT THERAPEUTICS, INC. and it’s time to vote!
You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the
availability of proxy material for the stockholder meeting to be held virtually on June 15, 2022.
Vote Virtually at the Meeting*
June 15, 2022
10:00 a.m., ET
Virtually at:
www.virtualshareholdermeeting.com/CKPT2022
*Please check the meeting materials for any special requirements for meeting attendance.
Smartphone users
Point your camera here and
vote without entering a
control number
V1.1
For complete information and to vote, visit www.ProxyVote.com
Control #
D83260-P73167
Get informed before you vote
View the Notice and Proxy Statement and Annual Report online at www.ProxyVote.com OR you can receive a free paper or email copy of
the material(s) by requesting prior to June 1, 2022. If you would like to request a copy of the material(s) for this and/or future stockholder
meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending
an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a
paper or email copy. |
| THIS IS NOT A VOTABLE BALLOT
This is an overview of the proposals being presented at the
upcoming stockholder meeting. Please follow the instructions on
the reverse side to vote these important matters.
Vote at www.ProxyVote.com
Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Sign up for E-delivery”.
Voting Items
Board
Recommends
D83261-P73167
01) Michael S. Weiss
02) Christian Bechon
03) Scott Boilen
04) Neil Herskowitz
05) James F. Oliviero
06) Lindsay A. Rosenwald, M.D.
07) Barry Salzman
1. Election of Directors
Nominees:
2. The ratification of appointment of BDO USA, LLP as independent registered public accounting firm for the year ending
December 31, 2022.
NOTE: Such other business as may properly come before the meeting or any adjournment thereof.
For
For |
Grafico Azioni Checkpoint Therapeutics (NASDAQ:CKPT)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Checkpoint Therapeutics (NASDAQ:CKPT)
Storico
Da Nov 2023 a Nov 2024
